Kiromic Biopharma Revenue and Competitors

Houston, TX USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kiromic Biopharma's estimated annual revenue is currently $7M per year.(i)
  • Kiromic Biopharma's estimated revenue per employee is $155,000

Employee Data

  • Kiromic Biopharma has 45 Employees.(i)
  • Kiromic Biopharma grew their employee count by 0% last year.

Kiromic Biopharma's People

NameTitleEmail/Phone
1
Chief StaffReveal Email/Phone
2
CEOReveal Email/Phone
3
CFOReveal Email/Phone
4
VP Research and DevelopmentReveal Email/Phone
5
Head ManufacturingReveal Email/Phone
6
VP, Regulatory Affairs and QualityReveal Email/Phone
7
Head Proteomic ResearchReveal Email/Phone
8
Head Quality ControlReveal Email/Phone
9
Interim Chief Operations OfficerReveal Email/Phone
10
Senior Director Manufacturing Science & TechnologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is Kiromic Biopharma?

Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company using our proprietary DIAMOND® artificial intelligence (AI) platform to discover and develop cell and gene therapies with a therapeutic focus on immuno-oncology and other diseases. Kiromic is in the process of developing a multi-indication allogeneic CAR-T cell therapy that exploits the natural potency of Gamma Delta T-cells to target solid cancers. From our heritage as a cancer vaccine development company, Kiromic is focused on discovering, developing, and commercializing novel immuno-oncology applications through its robust product pipeline. Our pipeline development is leveraged through the Company’s proprietary target discovery engine called \DIAMOND,\ where big data science meets target identification to dramatically compress the man-years and billions of drug development dollars required to develop a live drug. The Company maintains offices in Houston, Texas. To learn more, visit www.kiromic.com. NASDAQ: KRBP

keywords:N/A

N/A

Total Funding

45

Number of Employees

$7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.6M45-60%$1M
#2
$8.4M4536%$575M
#3
$5.2M45N/AN/A
#4
$7.5M45-2%$2.1B
#5
$8.8M45-13%N/A